secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRYKER CORP (SYK)
CIK:        0000310764
Form:       8-K
Filed at:   2024-01-30T23:59:59+00:00
Accession:  0000310764-24-000005
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stryker Q4 organic sales up 11.4%; FY23 revenue $20.5B; guides FY24 adj EPS $11.70-$12.00
--------------------------------------------------------------------------------

- Q4 organic net sales growth 11.4% to $5.8B; full year organic growth 11.5% to $20.5B.
- Q4 adjusted EPS $3.46 (+15.3% YoY); full year adjusted EPS $10.60 (+13.5%).
- Adjusted operating margin expanded 60 bps in Q4 to 27.2%; full year 24.2% (+40 bps).
- MedSurg & Neuro organic sales up 11.8% in Q4 and full year; Ortho & Spine up 10.7% Q4, 11.1% FY.
- FY2024 outlook: organic sales growth 7.5%-9.0%; adjusted EPS $11.70-$12.00.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/310764/000031076424000005/0000310764-24-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/310764/000031076424000005/syk-20240130.htm
  HTML page:      https://secwatch.observer/filing/0000310764-24-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer